Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Views on FDA regulation, pipeline updates, and first vs. next-generation systems.
No fingersticks needed? Plus, a look at the “thinnest CGM ever” from Dexcom and Verily
Launches in the next 12-18 months. What we’re excited about…!
TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!
Details on monthly test strip subscription plan and our first impressions.
Glucose, food, exercise, and even DIY closed loop on the phone
The artificial pancreas is here for those willing to build their own; what can manufacturers learn from OpenAPS?
A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!
How many people have type 1? What are the barriers to using new therapies? What outcomes matter beyond A1c?
Abbott’s free Android app for caregivers is now available
Understanding the UnitedHealthcare/Medtronic partnership in the context of the Affordable Care Act.
New OneTouch Reveal app works with Apple and Android phones. Plus, a future partnership to integrate WellDoc’s FDA-approved BlueStar software.
Brings real-time insulin tracking, history, and a bolus calculator to injectors; launch in 2017
How to test your receiver to make sure it is working properly.
Six systems expected by 2019, plus an FAQ! Which system is right for me?
Ease, comfort, and actionable patterns, but some challenges with insurance coverage
First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company
The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr
How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference
How one court ruling may reverse Medicare’s policy denying coverage of most CGMs

Pages